Cabinet makers link up with Australian Made

The Australian Made Campaign (AMCL) has welcomed the Australian Cabinet and Furniture Association (ACFA) as an associate to support the continued growth of Australia’s local furnishings and furniture manufacturing sector. NSW-based ACFA is one of Australia’s primary industry associations for furnishing, cabinetmaking and joinery manufacturers, along with the semi-national Australasian Furnishing Association, which is also…

Bluglass installs commercial-scale semiconductor equipment at Silverwater plant

Semiconductor technology developer Bluglass has completed the installation of its largest-ever remote plasma vapour deposition (RPCVD) manufacturing system (main picture) at its Silverwater plant in Sydney. The commercial-scale system, known as BLG-500, is capable of creating 6×6 semiconductor wafers or 42 two inch wafers for the production of laser diodes, LED and microLED industries. It…

Canberra to take the low road on electric vehicles

Comment by Peter Roberts The federal government appears likely to make no effort to support the establishment of electric vehicle manufacturing in Australia following the release of a new report. The report, funded by the Australian Renewable Energy Agency’s Advancing Renewables Programme, looked at the very low level of EV sales in Australia and decided…

Monday news briefs – stories you might have missed

Respiri secures global sales and distribution agreement Asthma management system developer Respiri has signed an exclusive agreement with pharmaceutical firm Cipla to sell its Wheezo asthma management device. Cipla will initially market Wheezo in Australia and New Zealand, with further territories including the United States, Europe and India also on Cipla’s radar. Initial minimum sales…

Recce Pharmaceuticals tests Covid treatment

Recce Pharmaceuticals will trial its anti-infective agents RECCE 327 and RECCE 529 against SARS- CoV-2. The company has teamed with North Carolina’s Path BioAnalytics to trial its broad-spectrum synthetic antibiotics which the company is commercialising to defeat resistant superbugs, Researchers at PBA will evaluate the company’s drug candidates in an ‘ex vivo respiratory organoid model…